BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Immune checkpoint inhibitors
1
Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials
1/16/2026 11:31:18 AM | Browse: 18 | Download: 20
2
Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical strategies
12/23/2025 6:25:19 AM | Browse: 18 | Download: 72
3
Risk elements and diagnostic indicators for asymptomatic immune checkpoint inhibitor-associated myocarditis in esophageal cancer
11/28/2025 3:10:35 AM | Browse: 39 | Download: 106
4
Breaking through the transarterial chemoembolization resistance barrier: Reshaping the treatment path for advanced liver cancer with triple therapy
11/21/2025 7:06:13 AM | Browse: 46 | Download: 91
5
When new therapies arrive, we should think more: The unseen challenges of immunotherapy-induced remodeling
11/21/2025 3:54:19 AM | Browse: 31 | Download: 64
6
Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence
10/24/2025 6:10:11 AM | Browse: 53 | Download: 162
7
Chemotherapy plus bevacizumab vs chemoimmunotherapy for metastatic colorectal cancer: Real-world analysis
9/15/2025 8:38:07 AM | Browse: 377 | Download: 232
8
Immune checkpoint molecules signal regulatory protein alpha in the development of hepatocellular carcinoma
9/15/2025 8:37:57 AM | Browse: 185 | Download: 153
9
Progress of immune checkpoint inhibitors in gastric cancer
8/14/2025 5:49:34 AM | Browse: 86 | Download: 182
10
Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors
8/14/2025 5:49:33 AM | Browse: 97 | Download: 212
11
Targeted therapy combined with immunotherapy vs trifluridine/tipiracil with bevacizumab as late-line therapy in metastatic colorectal cancer
8/5/2025 8:25:48 AM | Browse: 77 | Download: 260
12
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management
7/25/2025 12:09:41 PM | Browse: 112 | Download: 290
13
Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapy
7/22/2025 9:23:02 AM | Browse: 60 | Download: 204
14
Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review
7/9/2025 7:00:43 AM | Browse: 69 | Download: 230
15
Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer
6/26/2025 7:56:33 AM | Browse: 79 | Download: 378
16
Immunotherapy in gastrointestinal stromal tumors: Current landscape and future horizons
6/20/2025 8:05:11 AM | Browse: 65 | Download: 346
17
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift
6/13/2025 1:39:37 PM | Browse: 75 | Download: 409
18
Chemotherapy plus bevacizumab with or without anti-programmed death 1 immunotherapy as the second-line therapy in colorectal cancer
6/6/2025 3:09:44 AM | Browse: 55 | Download: 456
19
Evaluation of efficacy and safety of targeted therapy and immune checkpoint inhibitors in metastatic colorectal cancer
5/15/2025 10:28:57 AM | Browse: 68 | Download: 534
20
Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature
3/26/2025 10:16:45 AM | Browse: 63 | Download: 356
21
Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma
3/25/2025 4:18:56 PM | Browse: 127 | Download: 609
22
Combining immune checkpoint inhibitors with standard treatment regimens in advanced human epidermal growth factor receptor-2 positive gastric cancer patients
3/25/2025 4:18:44 PM | Browse: 74 | Download: 488
23
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
2/21/2025 10:12:48 AM | Browse: 153 | Download: 556
24
Efficacy and Safety of Radiotherapy in Patients with microsatellite stable or proficient mismatch repair Colorectal Cancer Liver Metastasis
2/14/2025 10:34:00 AM | Browse: 93 | Download: 623
25
Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma
1/21/2025 9:22:11 AM | Browse: 94 | Download: 655
26
CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma
1/20/2025 7:38:49 AM | Browse: 93 | Download: 548
27
Early identification and multidisciplinary management of immune checkpoint inhibitors associated colitis can improve patient outcomes
12/27/2024 1:37:13 PM | Browse: 111 | Download: 485
28
Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study
12/17/2024 9:21:49 AM | Browse: 91 | Download: 565
29
Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients
10/21/2024 7:03:24 AM | Browse: 140 | Download: 692
30
Machine learning algorithms able to predict the prognosis of gastric cancer patients treated with immune checkpoint inhibitors
10/16/2024 6:29:25 AM | Browse: 115 | Download: 605
31
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM | Browse: 154 | Download: 809
32
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
9/19/2024 12:00:22 PM | Browse: 136 | Download: 550
33
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
9/18/2024 11:53:42 AM | Browse: 122 | Download: 480
34
Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?
9/3/2024 8:54:07 AM | Browse: 118 | Download: 407
35
Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors
8/27/2024 8:41:52 AM | Browse: 132 | Download: 509
36
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
8/16/2024 8:03:14 AM | Browse: 195 | Download: 531
37
Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
7/12/2024 3:55:58 PM | Browse: 128 | Download: 605
38
Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies
7/12/2024 3:55:58 PM | Browse: 117 | Download: 293
39
Immunotherapy in gastric cancer with liver metastasis: Challenges and opportunities
6/30/2024 7:39:33 AM | Browse: 120 | Download: 416
40
Application of immune checkpoint inhibitors and microsatellite instability in gastric cancer
6/3/2024 8:49:14 AM | Browse: 115 | Download: 521
41
Combined hepatocellular cholangiocarcinoma: A clinicopathological update
5/22/2024 11:33:24 AM | Browse: 91 | Download: 445
42
Liver biopsy in the post-hepatitis C virus era in Japan
4/12/2024 4:45:44 PM | Browse: 148 | Download: 755
43
Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
4/3/2024 7:21:13 AM | Browse: 126 | Download: 423
44
PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports
3/22/2024 11:48:14 AM | Browse: 115 | Download: 627
45
Immunotherapy of gastric cancer: Present status and future perspectives
2/26/2024 1:28:46 PM | Browse: 217 | Download: 465
46
Prevention of hepatitis B reactivation in patients with hematologic malignancies treated with novel systemic therapies: Who and Why?
1/31/2024 7:03:00 AM | Browse: 205 | Download: 656
47
Revolutionizing gastric cancer treatment: The potential of immunotherapy
1/26/2024 7:56:28 AM | Browse: 343 | Download: 893
48
Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future
9/8/2023 9:01:55 AM | Browse: 249 | Download: 796
49
Systemic treatments for resectable carcinoma of the esophagus
8/10/2023 1:26:04 PM | Browse: 246 | Download: 935
50
Zimberelimab plus chemotherapy as the first-line treatment of malignant peritoneal mesothelioma: A case report and review of literature
8/3/2023 10:22:43 AM | Browse: 288 | Download: 1056